eISSN 2508-3589
pISSN 2508-1926

Table. 3.

Table. 3.

Changes in the visual acuity and retinal fluid component of patients with exudative age-related macular degeneration treated with a treat-and-extend regimen using intravitreal aflibercept injections

Characteristic 3 month 6 month 12 month
Change from baseline BCVA
Increase of ≥ 3 lines 10 (27.8) 10 (27.8) 13 (36.1)
Increase of 1-2 lines 8 (22.2) 10 (27.8) 11 (30.6)
Change of < 1 line 14 (38.9) 11 (30.6) 8 (22.2)
Decrease of 1-2 lines 4 (11.1) 5 (13.8) 4 (11.1)
Dry macular 21 (58.3) 23 (63.9) 25 (69.4)

Values are presented as number (%).

BCVA = best-corrected visual acuity.

J Retin 2021;6:99-109 https://doi.org/10.21561/jor.2021.6.2.99
© 2021 J Retin